Serum oligoclonal IgG is a common and persistent finding in multiple sclerosis, and has a systemic source

QJM: An International Journal of Medicine

Volumn 89, Issue 3, 1996, Pages 187-193

  Zeman, A Z J ^a,b,c   Keir, G ^b   Luxton, R ^b   Thompson, E J ^b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGE; ARTICLE; CELL CLONE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PLASMA CELL; PRIORITY JOURNAL;

EID: 0029867228     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.3.187     Document Type: Article

References (29)

1. Link H. The cerebrospinal fluid in multiple sclerosis. In: Swash M, Oxbury J, eds. Clinical Neurology. Edinburgh; Churchill Livingstone, 1991:1128-38.
2. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WI, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13:227-31.
3. Paterson PY, Whitacre CC. The enigma of oligoclonal IgG in cerebrospinal fluid from multiple sclerosis patients. Immunology Today 1981; 2:111-17.
4. Laurenzi MA, Mavra M, Kam-Hansen S, Link H. Oligoclonal IgG and free light chains in multiple sclerosis demonstrated by thin-layer polyacrylamide gel isoelectric focusing and immunofixation. Ann Neurol 1980; 8:241-7.
5. Mattson DH, Roos RP, Arnason BGW. Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Ann Neurol 1981; 9:34-41.
6. Staugaitis SM, Shapshak P, Tourtellotte WW, Lee MH, Reiber H-OO. Isoelectric focusing of unconcentrated cerebrospinal fluid: applications to ultrasensitive analysis of oligoclonal IgG. Electrophoresis 1985; 6:287-91.
7. Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29, suppl. 124:21-37.
8. Mancini G, Carbonara AD, Haemans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235-54.
9. Blennow K, Fredman P, Wallin A, Gottfries C-G, Skoog I, Wikkelso C, Svennerholm L. Protein analysis in cerebrospinal fluid, III: relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production. Eur Neurol 1993; 33:134-42.
10. Keir C, Luxton RW, Thompson EJ. Isoelectric focusing of cerebrospinal fluid IgG: an annotated update. Ann Clin Biochem 1990; 27:436-43.
11. Wells JV. Immunoglobulins: Biosynthesis and Metabolism. In: Fudenberg H, Stites DP, Caldwell JL, Wells JV, eds. Basic and Clinical Immunology. Los Altos, Lange, 1980:64-78.
12. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale. Neurology 1983; 33:1444-52.
13. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiat 1991; 54:683-8.
14. Brown RA, Swanson Beck J. Statistics on microcomputers: analysis of categorical data. J Clin Pathol 1989; 42:117-22.
15. McLean BN, Luxton RW, Thompson EJ. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological diseases using isoelectric focusing and the log-IgG index. Brain 1990; 113:1269-89.
16. Zeman A, McLean B, Keir G, Luxton R, Shareif M, Thompson E. The significance of serum oligoclonal bands in neurological disorders. J Neurol Neurosurg Psychiat 1993; 56:32-5.
17. Fredrikson S, Baig S, Link H. Immunoglobulin producing cells in bone marrow and blood of patients with multiple sclerosis and controls. J Neurol Neurosurg Psychiat 1991; 54:412-14.
18. Link H. Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Acta Neurol Scand 1967; 43(suppl. 28):1-136.
19. Tourtellotte WW, Potvin AR, Fleming JO, Murthy KN, Levy J, Syndulko K, Potvin JH. Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology 1980; 30:240-4.
20. Nagelkeren LM, Zoonen-van Exel Mv, Walbeek HKv, Aalberse RC, Out TA. Analysis of cerebrospinal fluid and serum of patients with multiple sclerosis by means of anti-idiotypic antisera. J Immunol 1982; 128:1102-6.
21. Tourtellotte WW, Baumhefner RW, Syndulko K, Shapshak P, Osborne M, Rubinshtein G, Newton G, Ellison G, Myers L, Rosario I, Thomsen R, Sloan R, Englemann S. The long march of the cerebrospinal fluid profile indicative of multiple sclerosis; and still marching. J Neuroimmunol 1988; 20:217-27.
22. Thompson EJ, Kaufmann P, Rudge P. Sequential changes in oligoclonal patterns during the course of multiple sclerosis. J Neurol Neurosurg Psychiat 1983; 46:547-50.
23. De Keyser J. Autoimmunity in multiple sclerosis. Neurology 1988; 38:371-4.
24. Roitt I. Essential Immunology. Oxford; Blackwell Scientific Publications, 1989.
25. Hafler DA, Weiner HL. MS: a CNS and systemic autoimmune disease. Immunology Today 1989; 10:104-7.
26. Reder A, Arnason B. Immunology of Multiple Sclerosis. In: Koetsier JC, ed. Handbook of Clinical Neurology, Volume 3(47): Demyelinating Diseases. Amsterdam; Elsevier, 1985:337-95.
27. Frei K, Fredrikson S, Fontana A, Link H. Interleukin-6 is elevated in plasma in multiple sclerosis. J Neuroimmunol 1991; 31:147-53.
28. Maimone D, Gregory S, Arnason BGW, Reder AT. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 1991; 32:67-74.
29. Link J, Soderstrom M, Olsson T, Hojeberg B, Ljungdahl A, Link H. Increased transforming growth factor-beta, interleukin-4 and interferon-gamma in multiple sclerosis. Ann Neurol 1994; 36:379-86.